Cresco Labs Stock Price, News & Analysis

Cresco Labs (CSE:CL) (OTCQX:CRLBF) announced the expiration of the waiting period under the Hart-Scott-Rodino Act regarding its acquisition of Bluma Wellness Inc. (CSE: BWEL.U) (OTCQX:BMWLF). The absence of a second request from the DOJ indicates a favorable outcome for the Transaction, expected to close in Q2 2021, pending final approvals. CEO Charles Bachtell expressed optimism about collaborating with Bluma to enhance Cresco's presence in the Florida market.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) announced it will report its financial results for Q4 and the full year ending December 31, 2020, on March 25, 2021, before market opens. A conference call will follow at 8:30 AM EDT to discuss these results and provide business highlights. Cresco Labs, a leading multistate cannabis operator, aims to normalize and professionalize the cannabis industry. It is also the largest wholesaler of branded cannabis products in the U.S., with a focus on consumer needs through multiple trusted brands.

Cresco Labs (CSE:CL) (OTCQX:CRLBF), a leading US cannabis operator, announced its participation in key investor conferences. Notable events include the Needham 2nd Annual Virtual Cannabis Conference on March 3, 2021, the 33rd Annual Roth Conference from March 15-17, 2021, where CEO Charlie Bachtell will host a Fireside Chat, and one-on-one meetings on April 7. Additionally, the Stifel Multi-Sector Conference on April 21 will feature management engagements. Cresco aims to foster a professional cannabis industry through its consumer-focused brands and extensive educational initiatives.

Cresco Labs (CSE:CL, OTCQX:CRLBF) has successfully acquired four Verdant Creations dispensaries in Ohio, expanding its total to five locations, the maximum permitted by state law. This acquisition enhances Cresco’s position in Ohio, which has seen a rapid increase in medical cannabis patients from 78,000 to 160,000 in 2020, along with annual cannabis sales nearing $220 million. The company plans to leverage its cultivation capacity and processing facility to boost its market presence in this growing state.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) has entered an exclusive distribution agreement with Emerald Family Farms (EFF), enhancing its California distribution capabilities. This collaboration will add EFF's sustainable cannabis products, including flower and concentrates, to Cresco's distribution platform, Continuum. EFF, a farmer co-op, is known for its commitment to quality and environmental stewardship. The partnership aims to bring premium cannabis products to consumers across California, supporting both companies' growth in the rapidly expanding cannabis market.

Cresco Labs (CSE:CL, OTCQX:CRLBF) has launched 1.0 g and 0.5 mg Live Cartridges from its High Supply line in California and Illinois. These products feature 100% cannabis oil enriched with live terpenes at competitive prices, aiming to attract both enthusiasts and value shoppers. The expansion continues Cresco's strategy of developing a diverse brand portfolio, enhancing its offerings in the cannabis sector. This initiative follows the recent introduction of Cresco’s 1.0 g liquid live resin vape cartridges, supporting solid growth in a highly competitive market.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) has successfully closed its overnight marketed offering of subordinate voting shares at C$16.00 per share, raising approximately US$125 million. The offering included sales in Canada (excluding Québec) and a private placement in the U.S. for qualified institutional buyers. Proceeds will be utilized for organic and inorganic growth initiatives and general corporate purposes. The offering was led by ATB Capital Markets Inc. as the sole bookrunner, with A.G.P./Alliance Global Partners serving as a financial advisor in the U.S.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) has appointed Ty Gent as the new Chief Operating Officer. Gent brings over 35 years of experience from the CPG industry, including roles at US Foods and PepsiCo, where he optimized supply chains and improved operational processes. His expertise will enhance Cresco's scalability and operational efficiency in the rapidly growing cannabis market. Concurrently, David Ellis transitions from COO to Regional President of Operations for Emerging Markets, focusing on replicating successful strategies in new states.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) reported that its employees contributed over 5,000 volunteer hours in 2020 through the 'Make a Difference' initiative. This initiative, started in June 2020, aimed to support communities amid social justice movements following incidents involving George Floyd and others. Volunteers worked across 28 cities in eight states, aiding over 50 organizations, packaging food, and addressing local needs. CEO Charlie Bachtell emphasized the company’s commitment to corporate social responsibility and community support.